1. Identify patients who are candidates for neoadjuvant chemotherapy in ovarian cancer
  2. Outline new indications for PARP inhibition in ovarian cancer
  3. Explain new treatment guidelines for the advanced/recurrent ovarian cancer
  4. Define recent changes in management of cervical cancer
  5. Summarize updated treatment options for advanced endometrial cancer

 

Event address for attendees: https://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=e7b348328c6a4aa72462b0da793d644a2

Session date: 
Wednesday, December 9, 2020 - 8:00am to 9:00am
Location: 
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Elsa Paplomata
Dr. Sumer Wallace